ArticleTheranostics2013

Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.

Shundong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.